Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-19

Clinical Trial Update: Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD

View source ↗

Summary

A completed trial evaluating renal function and pharmacogenetics in kidney transplant recipients after converting tacrolimus from twice-daily Prograf to once-da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advagraf (tacrolimus)
  • Prograf (Tacrolimus)

Snippet

Sponsor: Unity Health Toronto | Conditions: Real Function Post Conversion From Prograf to Advagraf, Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion | Status: COMPLETED